AG2R La Mondiale Gestion d'Actifs’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Sell
7,838
-537
-6% -$103K 0.06% 291
2026
Q1
$1.54M Buy
8,375
+111
+1% +$20.5K 0.07% 272
2025
Q4
$1.45M Buy
+8,264
New +$1.35M 0.06% 279
2025
Q2
Sell
-7,641
Closed -$992K 367
2025
Q1
$992K Buy
+7,641
New +$1.09M 0.05% 336

Other funds holding BIIB

AG2R La Mondiale Gestion d'Actifs's BIIB Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs reduced its Biogen (BIIB) stake by 6.4% in Q2 2026, selling an estimated $103K and leaving 7,838 shares worth $1.69M. The position accounts for 0.06% of the portfolio, ranked #291.

AG2R La Mondiale Gestion d'Actifs first reported a position in BIIB in Q1 2025 and has held it in 4 quarters since. 241 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • AG2R La Mondiale Gestion d'Actifs held 7,838 shares of Biogen worth $1.69M as of Q2 2026.
  • AG2R La Mondiale Gestion d'Actifs sold 537 Biogen shares in Q2 2026, an estimated $103K.
  • Biogen made up 0.06% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #291 holding.
  • AG2R La Mondiale Gestion d'Actifs first reported a position in Biogen in Q1 2025 and has held it in 4 quarters since.
  • 241 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.